Search
You're invited to try out the new version of Value Research Online. Click here to begin: https://beta.valueresearchonline.com

Mangalam Drugs & Organics

Sector: Healthcare | Industry: Drugs & Pharma
R 25.95 -0.15  | -0.57% -66.19% - 40.92
NSE Price: Oct 23, 15:48 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Oct 23, 15:48 25.95 -0.15 -0.57% 25.40 26.10 5,766 25.35 - 26.50
BSE Oct 23, 2019 25.85 -0.40 -1.52% 25.65 26.25 2,753 25.65 - 27.00
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
SUBSCRIBE TO THE VALUE RESEARCH STOCK INSIGHT NEWSLETTER
6M Average Volume: 14,813 P/B: 0.42 NSE Code: MANGALAM
52-Week Range: R 24.15 - 85.00 Dividend Yield: 0.00% BSE Code: 532637
TTM EPS: R -5.03 Book Value: R 60.96 Face Value: R 10
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 38
Price Graph
  • Eris Lifesciences (NSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Value Research Stock Advisor now has 38 stock recommendations and new ones are added every month.
Thousands of our members are using the current market conditions to buy great stocks at low prices.

Membership of this premium service is available at a 40% to 60% discount. Learn more and become a member
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Mangalam Drugs & Organics -64.69 -16.07 -27.29 -66.56 -45.72 7.44 7.71
S&P BSE Small Cap -10.09 -2.52 0.13 -3.04 -0.52 4.40 5.59
S&P BSE Healthcare -7.63 -0.83 0.63 -9.28 -7.66 -1.57 11.31
Company's return has been calculated on basis of BSE's price.
As on Oct 23, 2019
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue -18.54 -8.29 13.18
Net Profit -140.38 -179.42 -191.53
EPS -140.38 -176.91 -172.48
Book Value -7.72 17.93 27.98
Average
Operating Margin 4.39 12.24 11.76
Net Margin -3.52 3.64 3.83
Return on Networth -8.05 15.02 21.46
Return on Investment 1.76 19.09 20.42
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue 35.25 10.23 35.25
Operating Profit 1,071.22 12.33 1,071.22
Net Profit 112.30 10.63 112.30
EPS 112.30 10.64 112.30
TTM
Revenue 2.65 -17.52 2.65
Operating Profit 6.03 -75.16 6.03
Net Profit 0.88 -148.53 0.88
EPS 0.88 -148.53 0.88
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Mangalam Drugs & Organics 40.92 233.62 -7.96 -3.40 -8.05 0.42 -
Astrazeneca Pharma India 6,332.38 771.42 69.56 8.84 20.03 19.78 91.03
Eris Lifesciences 5,764.14 1,005.70 303.64 29.29 28.96 4.67 18.99
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Jun 25, 2019 SHREE KISHORIJU TRADING AND INVESTMENT PVT LTD  Buy Revocation of Pledge 199,664 31.35 62.59
Feb 15, 2019 Shree Kishoriju Trading & Investment Pvt Ltd  Sell Invocation Of Pledged 200,000 42.55 85.10
Oct 11, 2018 SICOM LTD  Buy Pledge 63,965 70.50 45.10
Oct 09, 2018 Shree Rasbihari Trading & Investment Pvt Ltd  Sell Invocation of Pledged 11,355 65.35 7.42
Oct 09, 2018 SICOM Ltd  Buy Pledge 72,500 65.35 47.38
Review & Analysis
News & Announcements
Contact Information

Company: Mangalam Drugs & Organics Ltd.

Address: ‘3” Floor, 237, Rupam Building, P. D. Mello Road, Mumbai, Maharashtra - 400001 | Phone: 91-22-22616200/ 6300/8787 | Fax: 91-22-2619090

Email: [email protected]

Website: www.mangalamdrugs.com

Registrar & Transfer Agent: Link Intime India Pvt Ltd.

Address: C 101, 247 Park, LBS Marg, Vikhroli (W), Mumbai(Old Address:) C-13 Pannalal Silk Compound, L B S Marg, Bhandup Mumbai Maharashtra, C 101, 247 Park, LBS Marg, Vikhroli (West) | Phone: 91-022-49186000/49186270 | Fax: 91-022-49186060

Email: [email protected]

Website: www.linkintime.co.in

Essential checks
Altman Z-Score
2.01
Piotroski F-Score
4
Modified C-Score
1
5-Years Price to Earnings
Not applicable
5-Years Price to Book
0.42
Earnings Yield
EBIT / Enterprise value
3.41%
PEG
Price / Earnings to growth ratio
Not available
Related Stocks
  Current Price   Chng %
Astrazeneca Pharma India R2,531.95 +4.97%
Caplin Point Laboratories R382.95 -1.24%
Eris Lifesciences R421.25 -0.98%
FDC R159.30 -1.03%
JB Chemicals & Pharma R355.00 -1.33%
Laurus Labs R348.00 +1.84%
Strides Pharma Science R343.50 -2.07%
Sun Pharma Adv. Research R129.30 -2.49%
Suven Life Sciences R288.40 +0.61%
Wockhardt R269.80 -1.96%
As on Oct 23, 15:59